- Poster Session
Posters 6: Oncology - Penis/Testis/Urethra & Prostate

Saturday June 25, 2022 | 16:00 to 17:30
Room: Aspen

Learning Objectives

As a result of attending this session, participants will be able to:

  • Get up to date with lastest in research on testis, penile, and prostate cancer
  • Expand network with colleagues 
  • Improve presentation skills

 


Presentations


16:30
MP-6.1

Dr. / Dr James Hayes
Natural history of small testis masses


16:34
MP-6.2

Dr. / Dr Esmail ES Al-Ezzi
The use of salvage chemotherapy for patients with relapsed testicular germ cell tumor in Canada: a national survey


16:38
MP-6.3

Mr. / M. William C. I. Janes
A quality assurance review of penile cancer diagnostic delays and advanced stage at presentation during the COVID-19 pandemic


16:42
MP-6.4

Dr. / Dr Mohamad Baker Berjaoui
Comparing and contrasting primary testicular lymphoma and germ cell tumors


16:46
MP-6.5

Dr. / Dr Mohamad Baker Berjaoui
Age related differences in primary testicular lymphoma : a large population based cohort study


16:50
MP-6.6

Dr. / Dr Loay Abbas
Holmium laser enucleation of the prostate to patients with bladder outlet obstruction, high PSA and negative prostatic biopsy is a reliable tool for missed prostate cancer diagnosis


16:54
MP-6.8

Dr. / Dr Raees Cassim
Robotic assisted radical cystectomy: experiences of a from a high volume robotic prostatectomy surgeon


16:58
MP-6.9

Dr. / Dr Ioana Fugaru
Partial Gland Ablation (PGA) with High Intensity Focal Ultrasound (HIFU) impact on urinary function and quality of life: our initial experience


17:02
MP-6.10

Dr. / Dr Braden Millan
Evaluation of peri-operative outcomes and predictors of successful same-day discharge after robot-assisted radical prostatectomy


17:06
MP-6.11

Dr. / Dr Kim N Chi
Heath-related quality of life, pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer


17:10
MP-6.12

Dr. / Dr Geoffrey Gotto
Darolutamide observational study in patients with non-metastatic castration-resistant prostate cancer




© 2024 CUA 77th Annual Meeting